Agilent Technologies Earnings Beat, Revenue Inline In Q4

© Reuters.

By Yasin Ebrahim – Agilent Technologies (NYSE:) reported fourth quarter that beat analysts’ expectations, while revenue was inline.

The firm reported earnings per share of $1.21 on revenue of $1.66 billion. Analysts polled by forecast EPS of $1.18 on revenue of $1.66 billion.

The diagnostics and genomics business generated fourth-quarter revenue of $341 million, up a reported 16% year over year while the Agilent CrossLab business posted fourth-quarter revenue of $572 million, representing year-over-year reported growth of 10%.

Looking ahead, fiscal first-quarter revenue guidance was in a range of $1.64 billion to $1.66 billion, and EPS between $1.16 and $1.18 per share. That compared with expectations for revenue of $1.66 billon on earnings of $1.16.

Fiscal year 2022 revenue was expected in the range of $6.65 billion to $6.73 billion, representing reported growth of 5.2% to 6.5%, with earnings guided in a range of $4.76 to $4.86 per share.

Stay up-to-date on all of the upcoming earnings reports by visiting’s earnings calendar

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.